Anti-FAM210A monoclonal antibody

Pre-made anti-FAM210A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to FAM210A/FAM210A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0818-Ab-1/ GM-Tg-hg-IP0818-Ab-2Anti-Human FAM210A monoclonal antibodyHuman
GM-Tg-rg-IP0818-Ab-1/ GM-Tg-rg-IP0818-Ab-2Anti-Rat FAM210A monoclonal antibodyRat
GM-Tg-mg-IP0818-Ab-1/ GM-Tg-mg-IP0818-Ab-2Anti-Mouse FAM210A monoclonal antibodyMouse
GM-Tg-cynog-IP0818-Ab-1/ GM-Tg-cynog-IP0818-Ab-2Anti-Cynomolgus/ Rhesus macaque FAM210A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0818-Ab-1/ GM-Tg-felg-IP0818-Ab-2Anti-Feline FAM210A monoclonal antibodyFeline
GM-Tg-cang-IP0818-Ab-1/ GM-Tg-cang-IP0818-Ab-2Anti-Canine FAM210A monoclonal antibodyCanine
GM-Tg-bovg-IP0818-Ab-1/ GM-Tg-bovg-IP0818-Ab-2Anti-Bovine FAM210A monoclonal antibodyBovine
GM-Tg-equg-IP0818-Ab-1/ GM-Tg-equg-IP0818-Ab-2Anti-Equine FAM210A monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0818-Ab-1/ GM-Tg-hg-IP0818-Ab-2; GM-Tg-rg-IP0818-Ab-1/ GM-Tg-rg-IP0818-Ab-2;
GM-Tg-mg-IP0818-Ab-1/ GM-Tg-mg-IP0818-Ab-2; GM-Tg-cynog-IP0818-Ab-1/ GM-Tg-cynog-IP0818-Ab-2;
GM-Tg-felg-IP0818-Ab-1/ GM-Tg-felg-IP0818-Ab-2; GM-Tg-cang-IP0818-Ab-1/ GM-Tg-cang-IP0818-Ab-2;
GM-Tg-bovg-IP0818-Ab-1/ GM-Tg-bovg-IP0818-Ab-2; GM-Tg-equg-IP0818-Ab-1/ GM-Tg-equg-IP0818-Ab-2
Products NameAnti-FAM210A monoclonal antibody
Formatmab
Target NameFAM210A
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-FAM210A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0818-Ag-1Recombinant multi-species F210A/ FAM210A/ C18orf19 protein


    Target information

    Target IDGM-IP0818
    Target NameFAM210A
    Gene ID125228,108654,307343,701669,476201,101093896,511554,100057183
    Gene Symbol and Synonyms4933403F05Rik,C18H18orf19,C18orf19,C1H18orf19,C24H18orf19,FAM210A,HsT2329,RGD1359600
    Uniprot AccessionQ96ND0,Q5XIJ4,Q05B67
    Uniprot Entry NameF210A_HUMAN,F210A_RAT,F210A_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000177150
    Target ClassificationN/A

    The target: FAM210A, gene name: FAM210A, also named as C18orf19, HsT2329. Predicted to be located in cytoplasm. Predicted to be active in mitochondrion. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.